Grants Awarded in 2014 – Congratulations to the following!
Dr. Steven Grover:
$448,245 from the Canadian
Institutes of Health Research for his study Canadian Health Improvement
Network to Upgrade Prevention Services (CHIN-UPS) –
Evaluating a multidisciplinary health promotion program in
Dr. Nandini Dendukuri
(with Lawrence Joseph):
$256,932 from CIHR – "Statistical methods to support
diagnosis of childhood tuberculosis in the absence of a
Dr. Nitika Pai: $198,394 (2 years) from CIHR HIV/AIDS
Research Initiative – "Evaluation of an HIV self-testing
strategy in community clinics for men who have sex with men"
Dr. Kaberi Dasgupta: $200,000 from the Lawson
Foundation Diabetes Funding Opportunity –
"The MoMMii study.
Effects of a multimodal diabetes prevention intervention on
families with a history of gestational diabetes"
(Theresa Gyorkos’ PhD Student): $10,000
from CIHR Planning and Dissemination Grant - Institute
Community Support – "Informing policy and practice on
deworming in early preschool-age children: from local to
Dr. Louise Pilote: $40,000 from the Heart and Stroke
Foundation – HAVEN, "Hypertension in the very elderly men
and women trial"
Dr. Sasha Bernatsky: $10,000 from the CIHR (Planning and
Dissemination Grant - Institute Community Support) –
Outcomes for Mothers with Rheumatic Diseases and their
Dr. Anne-Sophie Brazeau (Kaberi Dasgupta's post-doctoral student):
$40,000 per year two-year post
doc award from the Heart and Stroke Foundation to work on the MoMMii study.
Dr. Susan Bartlett (with Dr. Clifton
Bingham at Johns Hopkins University): $700,000 from PCORI – “Making PROMIS Meaningful to Patients and Providers in
Drs. Lesley Fellows and Nancy Mayo: $50,000
from the Heart and Stroke Foundation – Getting stroke
care pathways on the right track: Shifting the focus from
processes to outcomes.
The CAnadian Network
for Advanced Interdisciplinary Methods for
comparative effectiveness research
(CAN-AIM) team was funded by CIHR to develop novel
methods using prospective longitudinal cohorts and
to respond to key knowledge gaps regarding drug
safety and effectiveness by answering queries which
arise from Health Canada and other regulatory
parties. Our demonstration project looked at the
comparative effectiveness of anti-tumor necrosis
factor (TNF) agents versus traditional
disease-modifying agents (DMARDs) in reducing
orthopedic surgery in rheumatoid arthritis (RA).
For information on our preliminary results or for
more information on our team, please visit our
http://canaim.ca/ or contact Autumn Neville at
© 2014, Royal Victoria Hospital, All rights reserved.